a blank check company, which focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization
Industry Biotechnology
A.I.dvisor tells us that CELU and FATE have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CELU and FATE's prices will move in lockstep.
Ticker / NAME | Correlation To CELU | 1D Price Change % | ||
---|---|---|---|---|
CELU | 100% | +1.27% | ||
FATE - CELU | 27% Poorly correlated | +4.25% | ||
PRAX - CELU | 27% Poorly correlated | +0.67% | ||
RNAC - CELU | 26% Poorly correlated | +1.04% | ||
SAGE - CELU | 26% Poorly correlated | +0.63% | ||
HUMA - CELU | 25% Poorly correlated | +1.12% | ||
More |